APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lisdexamfetamine Dimesylate Capsules

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Lisdexamfetamine Dimesylate Capsules Market Analysis and Forecast 2026-2032

27 December 2025191 pages

Choose your research edition.

Industry ResearchLisdexamfetamine Dimesylate Capsules Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Lisdexamfetamine Dimesylate Capsules Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Lisdexamfetamine Dimesylate Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lisdexamfetamine Dimesylate Capsules Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Lisdexamfetamine Dimesylate Capsules Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Lisdexamfetamine Dimesylate Capsules market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Lisdexamfetamine Dimesylate Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Lisdexamfetamine Dimesylate Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Lisdexamfetamine Dimesylate Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Lisdexamfetamine Dimesylate Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Lisdexamfetamine Dimesylate Capsules include Zhejiang Huahai Pharmaceutical, Sun Pharmaceutical, Takeda Pharmaceutical, Teva Pharmaceutical, Sandoz, Mylan, Mallinckrodt PLC, Lannett and Hikma Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Lisdexamfetamine Dimesylate Capsules, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Lisdexamfetamine Dimesylate Capsules, also provides the sales of main regions and countries. Of the upcoming market potential for Lisdexamfetamine Dimesylate Capsules, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Lisdexamfetamine Dimesylate Capsules sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Lisdexamfetamine Dimesylate Capsules market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Lisdexamfetamine Dimesylate Capsules sales, projected growth trends, production technology, application and end-user industry.

Lisdexamfetamine Dimesylate Capsules Segment by Company

Zhejiang Huahai Pharmaceutical

Sun Pharmaceutical

Takeda Pharmaceutical

Teva Pharmaceutical

Sandoz

Mylan

Mallinckrodt PLC

Lannett

Hikma Pharmaceuticals

Ascent Pharmaceuticals

Apotex

Amneal Pharmaceuticals

Alkem Laboratories

Lisdexamfetamine Dimesylate Capsules Segment by Type

10mg per Unit

20mg per Unit

30mg per Unit

40mg per Unit

50mg per Unit

60mg per Unit

70mg per Unit

Lisdexamfetamine Dimesylate Capsules Segment by Application

Attention Deficit Hyperactivity Disorder(ADHD)

Bulimia

Other

Lisdexamfetamine Dimesylate Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lisdexamfetamine Dimesylate Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lisdexamfetamine Dimesylate Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lisdexamfetamine Dimesylate Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Lisdexamfetamine Dimesylate Capsules in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Lisdexamfetamine Dimesylate Capsules manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lisdexamfetamine Dimesylate Capsules sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Lisdexamfetamine Dimesylate Capsules Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 10mg per Unit Major Manufacturers Table 3. 20mg per Unit Major Manufacturers Table 4. 30mg per Unit Major Manufacturers Table 5. 40mg per Unit Major Manufacturers Table 6. 50mg per Unit Major Manufacturers Table 7. 60mg per Unit Major Manufacturers Table 8. 70mg per Unit Major Manufacturers Table 9. Global Lisdexamfetamine Dimesylate Capsules Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 10. Attention Deficit Hyperactivity Disorder(ADHD) Major Manufacturers Table 11. Bulimia Major Manufacturers Table 12. Other Major Manufacturers Table 13. Lisdexamfetamine Dimesylate Capsules Industry Trends Table 14. Lisdexamfetamine Dimesylate Capsules Industry Drivers Table 15. Lisdexamfetamine Dimesylate Capsules Industry Opportunities and Challenges Table 16. Lisdexamfetamine Dimesylate Capsules Industry Restraints Table 17. Global Lisdexamfetamine Dimesylate Capsules Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Lisdexamfetamine Dimesylate Capsules Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Lisdexamfetamine Dimesylate Capsules Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Region (2021-2026) Table 21. Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Region (2027-2032) Table 22. Global Lisdexamfetamine Dimesylate Capsules Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 23. Global Lisdexamfetamine Dimesylate Capsules Sales by Region (2021-2026) & (K Units) Table 24. Global Lisdexamfetamine Dimesylate Capsules Sales by Region (2027-2032) & (K Units) Table 25. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Region (2021-2026) Table 26. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Region (2027-2032) Table 27. Global Lisdexamfetamine Dimesylate Capsules Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Lisdexamfetamine Dimesylate Capsules Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Manufacturers (2021-2026) Table 31. Global Lisdexamfetamine Dimesylate Capsules Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 32. Global Lisdexamfetamine Dimesylate Capsules Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Lisdexamfetamine Dimesylate Capsules Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Lisdexamfetamine Dimesylate Capsules Manufacturers, Product Type & Application Table 35. Global Lisdexamfetamine Dimesylate Capsules Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Lisdexamfetamine Dimesylate Capsules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Lisdexamfetamine Dimesylate Capsules Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Lisdexamfetamine Dimesylate Capsules Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Lisdexamfetamine Dimesylate Capsules Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Type (2021-2026) Table 42. Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Type (2027-2032) Table 43. Global Lisdexamfetamine Dimesylate Capsules Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 44. Global Lisdexamfetamine Dimesylate Capsules Sales by Type (2021-2026) & (K Units) Table 45. Global Lisdexamfetamine Dimesylate Capsules Sales by Type (2027-2032) & (K Units) Table 46. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Type (2021-2026) Table 47. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Type (2027-2032) Table 48. Global Lisdexamfetamine Dimesylate Capsules Price by Type (2021-2026) & (US$/Unit) Table 49. Global Lisdexamfetamine Dimesylate Capsules Price by Type (2027-2032) & (US$/Unit) Table 50. Global Lisdexamfetamine Dimesylate Capsules Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Lisdexamfetamine Dimesylate Capsules Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Lisdexamfetamine Dimesylate Capsules Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Application (2021-2026) Table 54. Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Application (2027-2032) Table 55. Global Lisdexamfetamine Dimesylate Capsules Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 56. Global Lisdexamfetamine Dimesylate Capsules Sales by Application (2021-2026) & (K Units) Table 57. Global Lisdexamfetamine Dimesylate Capsules Sales by Application (2027-2032) & (K Units) Table 58. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Application (2021-2026) Table 59. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Application (2027-2032) Table 60. Global Lisdexamfetamine Dimesylate Capsules Price by Application (2021-2026) & (US$/Unit) Table 61. Global Lisdexamfetamine Dimesylate Capsules Price by Application (2027-2032) & (US$/Unit) Table 62. Zhejiang Huahai Pharmaceutical Company Information Table 63. Zhejiang Huahai Pharmaceutical Business Overview Table 64. Zhejiang Huahai Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Zhejiang Huahai Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 66. Zhejiang Huahai Pharmaceutical Recent Development Table 67. Sun Pharmaceutical Company Information Table 68. Sun Pharmaceutical Business Overview Table 69. Sun Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Sun Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 71. Sun Pharmaceutical Recent Development Table 72. Takeda Pharmaceutical Company Information Table 73. Takeda Pharmaceutical Business Overview Table 74. Takeda Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Takeda Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 76. Takeda Pharmaceutical Recent Development Table 77. Teva Pharmaceutical Company Information Table 78. Teva Pharmaceutical Business Overview Table 79. Teva Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Teva Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 81. Teva Pharmaceutical Recent Development Table 82. Sandoz Company Information Table 83. Sandoz Business Overview Table 84. Sandoz Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Sandoz Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 86. Sandoz Recent Development Table 87. Mylan Company Information Table 88. Mylan Business Overview Table 89. Mylan Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Mylan Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 91. Mylan Recent Development Table 92. Mallinckrodt PLC Company Information Table 93. Mallinckrodt PLC Business Overview Table 94. Mallinckrodt PLC Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Mallinckrodt PLC Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 96. Mallinckrodt PLC Recent Development Table 97. Lannett Company Information Table 98. Lannett Business Overview Table 99. Lannett Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Lannett Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 101. Lannett Recent Development Table 102. Hikma Pharmaceuticals Company Information Table 103. Hikma Pharmaceuticals Business Overview Table 104. Hikma Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Hikma Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 106. Hikma Pharmaceuticals Recent Development Table 107. Ascent Pharmaceuticals Company Information Table 108. Ascent Pharmaceuticals Business Overview Table 109. Ascent Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Ascent Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 111. Ascent Pharmaceuticals Recent Development Table 112. Apotex Company Information Table 113. Apotex Business Overview Table 114. Apotex Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Apotex Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 116. Apotex Recent Development Table 117. Amneal Pharmaceuticals Company Information Table 118. Amneal Pharmaceuticals Business Overview Table 119. Amneal Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Amneal Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 121. Amneal Pharmaceuticals Recent Development Table 122. Alkem Laboratories Company Information Table 123. Alkem Laboratories Business Overview Table 124. Alkem Laboratories Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Alkem Laboratories Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 126. Alkem Laboratories Recent Development Table 127. North America Lisdexamfetamine Dimesylate Capsules Revenue by Type (2021-2026) & (US$ Million) Table 128. North America Lisdexamfetamine Dimesylate Capsules Revenue by Type (2027-2032) & (US$ Million) Table 129. North America Lisdexamfetamine Dimesylate Capsules Sales by Type (2021-2026) & (K Units) Table 130. North America Lisdexamfetamine Dimesylate Capsules Sales by Type (2027-2032) & (K Units) Table 131. North America Lisdexamfetamine Dimesylate Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 132. North America Lisdexamfetamine Dimesylate Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 133. North America Lisdexamfetamine Dimesylate Capsules Revenue by Application (2021-2026) & (US$ Million) Table 134. North America Lisdexamfetamine Dimesylate Capsules Revenue by Application (2027-2032) & (US$ Million) Table 135. North America Lisdexamfetamine Dimesylate Capsules Sales by Application (2021-2026) & (K Units) Table 136. North America Lisdexamfetamine Dimesylate Capsules Sales by Application (2027-2032) & (K Units) Table 137. North America Lisdexamfetamine Dimesylate Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 138. North America Lisdexamfetamine Dimesylate Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 139. North America Lisdexamfetamine Dimesylate Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. North America Lisdexamfetamine Dimesylate Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 141. North America Lisdexamfetamine Dimesylate Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 142. North America Lisdexamfetamine Dimesylate Capsules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 143. North America Lisdexamfetamine Dimesylate Capsules Sales by Country (2021-2026) & (K Units) Table 144. North America Lisdexamfetamine Dimesylate Capsules Sales by Country (2027-2032) & (K Units) Table 145. North America Lisdexamfetamine Dimesylate Capsules Sales Price by Country (2021-2026) & (US$/Unit) Table 146. North America Lisdexamfetamine Dimesylate Capsules Sales Price by Country (2027-2032) & (US$/Unit) Table 147. United States Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032) & (US$ Million) Table 148. Canada Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032) & (US$ Million) Table 149. Mexico Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032) & (US$ Million) Table 150. Europe Lisdexamfetamine Dimesylate Capsules Revenue by Type (2021-2026) & (US$ Million) Table 151. Europe Lisdexamfetamine Dimesylate Capsules Revenue by Type (2027-2032) & (US$ Million) Table 152. Europe Lisdexamfetamine Dimesylate Capsules Sales by Type (2021-2026) & (K Units) Table 153. Europe Lisdexamfetamine Dimesylate Capsules Sales by Type (2027-2032) & (K Units) Table 154. Europe Lisdexamfetamine Dimesylate Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 155. Europe Lisdexamfetamine Dimesylate Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 156. Europe Lisdexamfetamine Dimesylate Capsules Revenue by Application (2021-2026) & (US$ Million) Table 157. Europe Lisdexamfetamine Dimesylate Capsules Revenue by Application (2027-2032) & (US$ Million) Table 158. Europe Lisdexamfetamine Dimesylate Capsules Sales by Application (2021-2026) & (K Units) Table 159. Europe Lisdexamfetamine Dimesylate Capsules Sales by Application (2027-2032) & (K Units) Table 160. Europe Lisdexamfetamine Dimesylate Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 161. Europe Lisdexamfetamine Dimesylate Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 162. Europe Lisdexamfetamine Dimesylate Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 163. Europe Lisdexamfetamine Dimesylate Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 164. Europe Lisdexamfetamine Dimesylate Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 165. Europe Lisdexamfetamine Dimesylate Capsules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 166. Europe Lisdexamfetamine Dimesylate Capsules Sales by Country (2021-2026) & (K Units) Table 167. Europe Lisdexamfetamine Dimesylate Capsules Sales by Country (2027-2032) & (K Units) Table 168. Europe Lisdexamfetamine Dimesylate Capsules Sales Price by Country (2021-2026) & (US$/Unit) Table 169. Europe Lisdexamfetamine Dimesylate Capsules Sales Price by Country (2027-2032) & (US$/Unit) Table 170. Germany Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032) & (US$ Million) Table 171. France Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032) & (US$ Million) Table 172. U.K. Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032) & (US$ Million) Table 173. Italy Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032) & (US$ Million) Table 174. Russia Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032) & (US$ Million) Table 175. Spain Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032) & (US$ Million) Table 176. Netherlands Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032) & (US$ Million) Table 177. Switzerland Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032) & (US$ Million) Table 178. Sweden Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032) & (US$ Million) Table 179. Poland Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032) & (US$ Million) Table 180. China Lisdexamfetamine Dimesylate Capsules Revenue by Type (2021-2026) & (US$ Million) Table 181. China Lisdexamfetamine Dimesylate Capsules Revenue by Type (2027-2032) & (US$ Million) Table 182. China Lisdexamfetamine Dimesylate Capsules Sales by Type (2021-2026) & (K Units) Table 183. China Lisdexamfetamine Dimesylate Capsules Sales by Type (2027-2032) & (K Units) Table 184. China Lisdexamfetamine Dimesylate Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 185. China Lisdexamfetamine Dimesylate Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 186. China Lisdexamfetamine Dimesylate Capsules Revenue by Application (2021-2026) & (US$ Million) Table 187. China Lisdexamfetamine Dimesylate Capsules Revenue by Application (2027-2032) & (US$ Million) Table 188. China Lisdexamfetamine Dimesylate Capsules Sales by Application (2021-2026) & (K Units) Table 189. China Lisdexamfetamine Dimesylate Capsules Sales by Application (2027-2032) & (K Units) Table 190. China Lisdexamfetamine Dimesylate Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 191. China Lisdexamfetamine Dimesylate Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 192. Asia Lisdexamfetamine Dimesylate Capsules Revenue by Type (2021-2026) & (US$ Million) Table 193. Asia Lisdexamfetamine Dimesylate Capsules Revenue by Type (2027-2032) & (US$ Million) Table 194. Asia Lisdexamfetamine Dimesylate Capsules Sales by Type (2021-2026) & (K Units) Table 195. Asia Lisdexamfetamine Dimesylate Capsules Sales by Type (2027-2032) & (K Units) Table 196. Asia Lisdexamfetamine Dimesylate Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 197. Asia Lisdexamfetamine Dimesylate Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 198. Asia Lisdexamfetamine Dimesylate Capsules Revenue by Application (2021-2026) & (US$ Million) Table 199. Asia Lisdexamfetamine Dimesylate Capsules Revenue by Application (2027-2032) & (US$ Million) Table 200. Asia Lisdexamfetamine Dimesylate Capsules Sales by Application (2021-2026) & (K Units) Table 201. Asia Lisdexamfetamine Dimesylate Capsules Sales by Application (2027-2032) & (K Units) Table 202. Asia Lisdexamfetamine Dimesylate Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 203. Asia Lisdexamfetamine Dimesylate Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 204. Asia Lisdexamfetamine Dimesylate Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 205. Asia Lisdexamfetamine Dimesylate Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 206. Asia Lisdexamfetamine Dimesylate Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 207. Asia Lisdexamfetamine Dimesylate Capsules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 208. Asia Lisdexamfetamine Dimesylate Capsules Sales by Country (2021-2026) & (K Units) Table 209. Asia Lisdexamfetamine Dimesylate Capsules Sales by Country (2027-2032) & (K Units) Table 210. Asia Lisdexamfetamine Dimesylate Capsules Sales Price by Country (2021-2026) & (US$/Unit) Table 211. Asia Lisdexamfetamine Dimesylate Capsules Sales Price by Country (2027-2032) & (US$/Unit) Table 212. Japan Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032) & (US$ Million) Table 213. South Korea Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032) & (US$ Million) Table 214. India Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032) & (US$ Million) Table 215. Australia Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032) & (US$ Million) Table 216. Taiwan Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032) & (US$ Million) Table 217. Southeast Asia Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032) & (US$ Million) Table 218. SAMEA Lisdexamfetamine Dimesylate Capsules Revenue by Type (2021-2026) & (US$ Million) Table 219. SAMEA Lisdexamfetamine Dimesylate Capsules Revenue by Type (2027-2032) & (US$ Million) Table 220. SAMEA Lisdexamfetamine Dimesylate Capsules Sales by Type (2021-2026) & (K Units) Table 221. SAMEA Lisdexamfetamine Dimesylate Capsules Sales by Type (2027-2032) & (K Units) Table 222. SAMEA Lisdexamfetamine Dimesylate Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 223. SAMEA Lisdexamfetamine Dimesylate Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 224. SAMEA Lisdexamfetamine Dimesylate Capsules Revenue by Application (2021-2026) & (US$ Million) Table 225. SAMEA Lisdexamfetamine Dimesylate Capsules Revenue by Application (2027-2032) & (US$ Million) Table 226. SAMEA Lisdexamfetamine Dimesylate Capsules Sales by Application (2021-2026) & (K Units) Table 227. SAMEA Lisdexamfetamine Dimesylate Capsules Sales by Application (2027-2032) & (K Units) Table 228. SAMEA Lisdexamfetamine Dimesylate Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 229. SAMEA Lisdexamfetamine Dimesylate Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 230. SAMEA Lisdexamfetamine Dimesylate Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 231. SAMEA Lisdexamfetamine Dimesylate Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 232. SAMEA Lisdexamfetamine Dimesylate Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 233. SAMEA Lisdexamfetamine Dimesylate Capsules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 234. SAMEA Lisdexamfetamine Dimesylate Capsules Sales by Country (2021-2026) & (K Units) Table 235. SAMEA Lisdexamfetamine Dimesylate Capsules Sales by Country (2027-2032) & (K Units) Table 236. SAMEA Lisdexamfetamine Dimesylate Capsules Sales Price by Country (2021-2026) & (US$/Unit) Table 237. SAMEA Lisdexamfetamine Dimesylate Capsules Sales Price by Country (2027-2032) & (US$/Unit) Table 238. Brazil Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032) & (US$ Million) Table 239. Argentina Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032) & (US$ Million) Table 240. Chile Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032) & (US$ Million) Table 241. Colombia Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032) & (US$ Million) Table 242. Peru Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032) & (US$ Million) Table 243. Saudi Arabia Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032) & (US$ Million) Table 244. Israel Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032) & (US$ Million) Table 245. UAE Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032) & (US$ Million) Table 246. Turkey Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032) & (US$ Million) Table 247. Iran Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032) & (US$ Million) Table 248. Egypt Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032) & (US$ Million) Table 249. Key Raw Materials Table 250. Raw Materials Key Suppliers Table 251. Lisdexamfetamine Dimesylate Capsules Distributors List Table 252. Lisdexamfetamine Dimesylate Capsules Customers List Table 253. Research Programs/Design for This Report Table 254. Authors List of This Report Table 255. Secondary Sources Table 256. Primary Sources List of Figures Figure 1. Lisdexamfetamine Dimesylate Capsules Image Figure 2. Global Lisdexamfetamine Dimesylate Capsules Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lisdexamfetamine Dimesylate Capsules Market Size Share 2021 VS 2025 VS 2032 Figure 4. 10mg per Unit Image Figure 5. 20mg per Unit Image Figure 6. 30mg per Unit Image Figure 7. 40mg per Unit Image Figure 8. 50mg per Unit Image Figure 9. 60mg per Unit Image Figure 10. 70mg per Unit Image Figure 11. Global Lisdexamfetamine Dimesylate Capsules Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Lisdexamfetamine Dimesylate Capsules Market Size Share 2021 VS 2025 VS 2032 Figure 13. Attention Deficit Hyperactivity Disorder(ADHD) Image Figure 14. Bulimia Image Figure 15. Other Image Figure 16. Global Lisdexamfetamine Dimesylate Capsules Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032) & (US$ Million) Figure 18. Global Lisdexamfetamine Dimesylate Capsules Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Region (2021-2032) Figure 21. Global Lisdexamfetamine Dimesylate Capsules Sales (2021-2032) & (K Units) Figure 22. Global Lisdexamfetamine Dimesylate Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 23. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Lisdexamfetamine Dimesylate Capsules Sales YoY (2021-2032) & (K Units) Figure 25. Europe Lisdexamfetamine Dimesylate Capsules Sales YoY (2021-2032) & (K Units) Figure 26. China Lisdexamfetamine Dimesylate Capsules Sales YoY (2021-2032) & (K Units) Figure 27. Asia (Excluding China) Lisdexamfetamine Dimesylate Capsules Sales YoY (2021-2032) & (K Units) Figure 28. South America, Middle East and Africa Lisdexamfetamine Dimesylate Capsules Sales YoY (2021-2032) & (K Units) Figure 29. Global Lisdexamfetamine Dimesylate Capsules Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Lisdexamfetamine Dimesylate Capsules Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Lisdexamfetamine Dimesylate Capsules Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Type (2021-2032) Figure 35. Global Lisdexamfetamine Dimesylate Capsules Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Type (2021-2032) Figure 38. Global Lisdexamfetamine Dimesylate Capsules Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Application (2021-2032) Figure 41. Global Lisdexamfetamine Dimesylate Capsules Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 42. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Application (2021-2032) Figure 44. North America Lisdexamfetamine Dimesylate Capsules Revenue Share by Type (2021-2032) Figure 45. North America Lisdexamfetamine Dimesylate Capsules Sales Share by Type (2021-2032) Figure 46. North America Lisdexamfetamine Dimesylate Capsules Revenue Share by Application (2021-2032) Figure 47. North America Lisdexamfetamine Dimesylate Capsules Sales Share by Application (2021-2032) Figure 48. North America Lisdexamfetamine Dimesylate Capsules Revenue Share by Country (2021-2032) Figure 49. North America Lisdexamfetamine Dimesylate Capsules Sales Share by Country (2021-2032) Figure 50. Europe Lisdexamfetamine Dimesylate Capsules Revenue Share by Type (2021-2032) Figure 51. Europe Lisdexamfetamine Dimesylate Capsules Sales Share by Type (2021-2032) Figure 52. Europe Lisdexamfetamine Dimesylate Capsules Revenue Share by Application (2021-2032) Figure 53. Europe Lisdexamfetamine Dimesylate Capsules Sales Share by Application (2021-2032) Figure 54. Europe Lisdexamfetamine Dimesylate Capsules Revenue Share by Country (2021-2032) Figure 55. Europe Lisdexamfetamine Dimesylate Capsules Sales Share by Country (2021-2032) Figure 56. China Lisdexamfetamine Dimesylate Capsules Revenue Share by Type (2021-2032) Figure 57. China Lisdexamfetamine Dimesylate Capsules Sales Share by Type (2021-2032) Figure 58. China Lisdexamfetamine Dimesylate Capsules Revenue Share by Application (2021-2032) Figure 59. China Lisdexamfetamine Dimesylate Capsules Sales Share by Application (2021-2032) Figure 60. Asia Lisdexamfetamine Dimesylate Capsules Revenue Share by Type (2021-2032) Figure 61. Asia Lisdexamfetamine Dimesylate Capsules Sales Share by Type (2021-2032) Figure 62. Asia Lisdexamfetamine Dimesylate Capsules Revenue Share by Application (2021-2032) Figure 63. Asia Lisdexamfetamine Dimesylate Capsules Sales Share by Application (2021-2032) Figure 64. Asia Lisdexamfetamine Dimesylate Capsules Revenue Share by Country (2021-2032) Figure 65. Asia Lisdexamfetamine Dimesylate Capsules Sales Share by Country (2021-2032) Figure 66. SAMEA Lisdexamfetamine Dimesylate Capsules Revenue Share by Type (2021-2032) Figure 67. SAMEA Lisdexamfetamine Dimesylate Capsules Sales Share by Type (2021-2032) Figure 68. SAMEA Lisdexamfetamine Dimesylate Capsules Revenue Share by Application (2021-2032) Figure 69. SAMEA Lisdexamfetamine Dimesylate Capsules Sales Share by Application (2021-2032) Figure 70. SAMEA Lisdexamfetamine Dimesylate Capsules Revenue Share by Country (2021-2032) Figure 71. SAMEA Lisdexamfetamine Dimesylate Capsules Sales Share by Country (2021-2032) Figure 72. Lisdexamfetamine Dimesylate Capsules Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Lisdexamfetamine Dimesylate Capsules Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg per Unit
  • 20mg per Unit
  • 30mg per Unit
  • 40mg per Unit
  • 50mg per Unit
  • 60mg per Unit
  • 70mg per Unit
Applications
  • Attention Deficit Hyperactivity Disorder(ADHD)
  • Bulimia
  • Other
Companies covered
  • Zhejiang Huahai Pharmaceutical
  • Sun Pharmaceutical
  • Takeda Pharmaceutical
  • Teva Pharmaceutical
  • Sandoz
  • Mylan
  • Mallinckrodt PLC
  • Lannett
  • Hikma Pharmaceuticals
  • Ascent Pharmaceuticals
  • Apotex
  • Amneal Pharmaceuticals
  • Alkem Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Lisdexamfetamine Dimesylate Capsules Market by Type
  3. 1.2.1 Global Lisdexamfetamine Dimesylate Capsules Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 10mg per Unit
  5. 1.2.3 20mg per Unit
  6. 1.2.4 30mg per Unit
  7. 1.2.5 40mg per Unit
  8. 1.2.6 50mg per Unit
  9. 1.2.7 60mg per Unit
  10. 1.2.8 70mg per Unit
  11. 1.3 Lisdexamfetamine Dimesylate Capsules Market by Application
  12. 1.3.1 Global Lisdexamfetamine Dimesylate Capsules Market Size by Application, 2021 VS 2025 VS 2032
  13. 1.3.2 Attention Deficit Hyperactivity Disorder(ADHD)
  14. 1.3.3 Bulimia
  15. 1.3.4 Other
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Lisdexamfetamine Dimesylate Capsules Market Dynamics
  1. 2.1 Lisdexamfetamine Dimesylate Capsules Industry Trends
  2. 2.2 Lisdexamfetamine Dimesylate Capsules Industry Drivers
  3. 2.3 Lisdexamfetamine Dimesylate Capsules Industry Opportunities and Challenges
  4. 2.4 Lisdexamfetamine Dimesylate Capsules Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Lisdexamfetamine Dimesylate Capsules Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Lisdexamfetamine Dimesylate Capsules Revenue by Region
  3. 3.2.1 Global Lisdexamfetamine Dimesylate Capsules Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Lisdexamfetamine Dimesylate Capsules Revenue by Region (2021-2026)
  5. 3.2.3 Global Lisdexamfetamine Dimesylate Capsules Revenue by Region (2027-2032)
  6. 3.2.4 Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Lisdexamfetamine Dimesylate Capsules Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Lisdexamfetamine Dimesylate Capsules Sales by Region
  9. 3.4.1 Global Lisdexamfetamine Dimesylate Capsules Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Lisdexamfetamine Dimesylate Capsules Sales by Region (2021-2026)
  11. 3.4.3 Global Lisdexamfetamine Dimesylate Capsules Sales by Region (2027-2032)
  12. 3.4.4 Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Lisdexamfetamine Dimesylate Capsules Revenue by Manufacturers
  2. 4.1.1 Global Lisdexamfetamine Dimesylate Capsules Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Lisdexamfetamine Dimesylate Capsules Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Lisdexamfetamine Dimesylate Capsules Sales by Manufacturers
  6. 4.2.1 Global Lisdexamfetamine Dimesylate Capsules Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Lisdexamfetamine Dimesylate Capsules Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Lisdexamfetamine Dimesylate Capsules Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Lisdexamfetamine Dimesylate Capsules Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Lisdexamfetamine Dimesylate Capsules Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Lisdexamfetamine Dimesylate Capsules Manufacturers, Product Type & Application
  13. 4.7 Global Lisdexamfetamine Dimesylate Capsules Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Lisdexamfetamine Dimesylate Capsules Market CR5 and HHI
  16. 4.8.2 2025 Lisdexamfetamine Dimesylate Capsules Tier 1, Tier 2, and Tier 3
5 Lisdexamfetamine Dimesylate Capsules Market by Type
  1. 5.1 Global Lisdexamfetamine Dimesylate Capsules Revenue by Type
  2. 5.1.1 Global Lisdexamfetamine Dimesylate Capsules Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Lisdexamfetamine Dimesylate Capsules Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Lisdexamfetamine Dimesylate Capsules Sales by Type
  6. 5.2.1 Global Lisdexamfetamine Dimesylate Capsules Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lisdexamfetamine Dimesylate Capsules Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Type (2021-2032)
  9. 5.3 Global Lisdexamfetamine Dimesylate Capsules Price by Type
6 Lisdexamfetamine Dimesylate Capsules Market by Application
  1. 6.1 Global Lisdexamfetamine Dimesylate Capsules Revenue by Application
  2. 6.1.1 Global Lisdexamfetamine Dimesylate Capsules Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Lisdexamfetamine Dimesylate Capsules Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Lisdexamfetamine Dimesylate Capsules Sales by Application
  6. 6.2.1 Global Lisdexamfetamine Dimesylate Capsules Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Lisdexamfetamine Dimesylate Capsules Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Application (2021-2032)
  9. 6.3 Global Lisdexamfetamine Dimesylate Capsules Price by Application
7 Company Profiles
  1. 7.1 Zhejiang Huahai Pharmaceutical
  2. 7.1.1 Zhejiang Huahai Pharmaceutical Company Information
  3. 7.1.2 Zhejiang Huahai Pharmaceutical Business Overview
  4. 7.1.3 Zhejiang Huahai Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Zhejiang Huahai Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio
  6. 7.1.5 Zhejiang Huahai Pharmaceutical Recent Developments
  7. 7.2 Sun Pharmaceutical
  8. 7.2.1 Sun Pharmaceutical Company Information
  9. 7.2.2 Sun Pharmaceutical Business Overview
  10. 7.2.3 Sun Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sun Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio
  12. 7.2.5 Sun Pharmaceutical Recent Developments
  13. 7.3 Takeda Pharmaceutical
  14. 7.3.1 Takeda Pharmaceutical Company Information
  15. 7.3.2 Takeda Pharmaceutical Business Overview
  16. 7.3.3 Takeda Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Takeda Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio
  18. 7.3.5 Takeda Pharmaceutical Recent Developments
  19. 7.4 Teva Pharmaceutical
  20. 7.4.1 Teva Pharmaceutical Company Information
  21. 7.4.2 Teva Pharmaceutical Business Overview
  22. 7.4.3 Teva Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Teva Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio
  24. 7.4.5 Teva Pharmaceutical Recent Developments
  25. 7.5 Sandoz
  26. 7.5.1 Sandoz Company Information
  27. 7.5.2 Sandoz Business Overview
  28. 7.5.3 Sandoz Lisdexamfetamine Dimesylate Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Sandoz Lisdexamfetamine Dimesylate Capsules Product Portfolio
  30. 7.5.5 Sandoz Recent Developments
  31. 7.6 Mylan
  32. 7.6.1 Mylan Company Information
  33. 7.6.2 Mylan Business Overview
  34. 7.6.3 Mylan Lisdexamfetamine Dimesylate Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Mylan Lisdexamfetamine Dimesylate Capsules Product Portfolio
  36. 7.6.5 Mylan Recent Developments
  37. 7.7 Mallinckrodt PLC
  38. 7.7.1 Mallinckrodt PLC Company Information
  39. 7.7.2 Mallinckrodt PLC Business Overview
  40. 7.7.3 Mallinckrodt PLC Lisdexamfetamine Dimesylate Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Mallinckrodt PLC Lisdexamfetamine Dimesylate Capsules Product Portfolio
  42. 7.7.5 Mallinckrodt PLC Recent Developments
  43. 7.8 Lannett
  44. 7.8.1 Lannett Company Information
  45. 7.8.2 Lannett Business Overview
  46. 7.8.3 Lannett Lisdexamfetamine Dimesylate Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Lannett Lisdexamfetamine Dimesylate Capsules Product Portfolio
  48. 7.8.5 Lannett Recent Developments
  49. 7.9 Hikma Pharmaceuticals
  50. 7.9.1 Hikma Pharmaceuticals Company Information
  51. 7.9.2 Hikma Pharmaceuticals Business Overview
  52. 7.9.3 Hikma Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Hikma Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Product Portfolio
  54. 7.9.5 Hikma Pharmaceuticals Recent Developments
  55. 7.10 Ascent Pharmaceuticals
  56. 7.10.1 Ascent Pharmaceuticals Company Information
  57. 7.10.2 Ascent Pharmaceuticals Business Overview
  58. 7.10.3 Ascent Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Ascent Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Product Portfolio
  60. 7.10.5 Ascent Pharmaceuticals Recent Developments
  61. 7.11 Apotex
  62. 7.11.1 Apotex Company Information
  63. 7.11.2 Apotex Business Overview
  64. 7.11.3 Apotex Lisdexamfetamine Dimesylate Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Apotex Lisdexamfetamine Dimesylate Capsules Product Portfolio
  66. 7.11.5 Apotex Recent Developments
  67. 7.12 Amneal Pharmaceuticals
  68. 7.12.1 Amneal Pharmaceuticals Company Information
  69. 7.12.2 Amneal Pharmaceuticals Business Overview
  70. 7.12.3 Amneal Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Amneal Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Product Portfolio
  72. 7.12.5 Amneal Pharmaceuticals Recent Developments
  73. 7.13 Alkem Laboratories
  74. 7.13.1 Alkem Laboratories Company Information
  75. 7.13.2 Alkem Laboratories Business Overview
  76. 7.13.3 Alkem Laboratories Lisdexamfetamine Dimesylate Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Alkem Laboratories Lisdexamfetamine Dimesylate Capsules Product Portfolio
  78. 7.13.5 Alkem Laboratories Recent Developments
8 North America
  1. 8.1 North America Lisdexamfetamine Dimesylate Capsules Market Size by Type
  2. 8.1.1 North America Lisdexamfetamine Dimesylate Capsules Revenue by Type (2021-2032)
  3. 8.1.2 North America Lisdexamfetamine Dimesylate Capsules Sales by Type (2021-2032)
  4. 8.1.3 North America Lisdexamfetamine Dimesylate Capsules Price by Type (2021-2032)
  5. 8.2 North America Lisdexamfetamine Dimesylate Capsules Market Size by Application
  6. 8.2.1 North America Lisdexamfetamine Dimesylate Capsules Revenue by Application (2021-2032)
  7. 8.2.2 North America Lisdexamfetamine Dimesylate Capsules Sales by Application (2021-2032)
  8. 8.2.3 North America Lisdexamfetamine Dimesylate Capsules Price by Application (2021-2032)
  9. 8.3 North America Lisdexamfetamine Dimesylate Capsules Market Size by Country
  10. 8.3.1 North America Lisdexamfetamine Dimesylate Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Lisdexamfetamine Dimesylate Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Lisdexamfetamine Dimesylate Capsules Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Lisdexamfetamine Dimesylate Capsules Market Size by Type
  2. 9.1.1 Europe Lisdexamfetamine Dimesylate Capsules Revenue by Type (2021-2032)
  3. 9.1.2 Europe Lisdexamfetamine Dimesylate Capsules Sales by Type (2021-2032)
  4. 9.1.3 Europe Lisdexamfetamine Dimesylate Capsules Price by Type (2021-2032)
  5. 9.2 Europe Lisdexamfetamine Dimesylate Capsules Market Size by Application
  6. 9.2.1 Europe Lisdexamfetamine Dimesylate Capsules Revenue by Application (2021-2032)
  7. 9.2.2 Europe Lisdexamfetamine Dimesylate Capsules Sales by Application (2021-2032)
  8. 9.2.3 Europe Lisdexamfetamine Dimesylate Capsules Price by Application (2021-2032)
  9. 9.3 Europe Lisdexamfetamine Dimesylate Capsules Market Size by Country
  10. 9.3.1 Europe Lisdexamfetamine Dimesylate Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Lisdexamfetamine Dimesylate Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Lisdexamfetamine Dimesylate Capsules Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Lisdexamfetamine Dimesylate Capsules Market Size by Type
  2. 10.1.1 China Lisdexamfetamine Dimesylate Capsules Revenue by Type (2021-2032)
  3. 10.1.2 China Lisdexamfetamine Dimesylate Capsules Sales by Type (2021-2032)
  4. 10.1.3 China Lisdexamfetamine Dimesylate Capsules Price by Type (2021-2032)
  5. 10.2 China Lisdexamfetamine Dimesylate Capsules Market Size by Application
  6. 10.2.1 China Lisdexamfetamine Dimesylate Capsules Revenue by Application (2021-2032)
  7. 10.2.2 China Lisdexamfetamine Dimesylate Capsules Sales by Application (2021-2032)
  8. 10.2.3 China Lisdexamfetamine Dimesylate Capsules Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Lisdexamfetamine Dimesylate Capsules Market Size by Type
  2. 11.1.1 Asia Lisdexamfetamine Dimesylate Capsules Revenue by Type (2021-2032)
  3. 11.1.2 Asia Lisdexamfetamine Dimesylate Capsules Sales by Type (2021-2032)
  4. 11.1.3 Asia Lisdexamfetamine Dimesylate Capsules Price by Type (2021-2032)
  5. 11.2 Asia Lisdexamfetamine Dimesylate Capsules Market Size by Application
  6. 11.2.1 Asia Lisdexamfetamine Dimesylate Capsules Revenue by Application (2021-2032)
  7. 11.2.2 Asia Lisdexamfetamine Dimesylate Capsules Sales by Application (2021-2032)
  8. 11.2.3 Asia Lisdexamfetamine Dimesylate Capsules Price by Application (2021-2032)
  9. 11.3 Asia Lisdexamfetamine Dimesylate Capsules Market Size by Country
  10. 11.3.1 Asia Lisdexamfetamine Dimesylate Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Lisdexamfetamine Dimesylate Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Lisdexamfetamine Dimesylate Capsules Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Lisdexamfetamine Dimesylate Capsules Market Size by Type
  2. 12.1.1 SAMEA Lisdexamfetamine Dimesylate Capsules Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Lisdexamfetamine Dimesylate Capsules Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Lisdexamfetamine Dimesylate Capsules Price by Type (2021-2032)
  5. 12.2 SAMEA Lisdexamfetamine Dimesylate Capsules Market Size by Application
  6. 12.2.1 SAMEA Lisdexamfetamine Dimesylate Capsules Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Lisdexamfetamine Dimesylate Capsules Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Lisdexamfetamine Dimesylate Capsules Price by Application (2021-2032)
  9. 12.3 SAMEA Lisdexamfetamine Dimesylate Capsules Market Size by Country
  10. 12.3.1 SAMEA Lisdexamfetamine Dimesylate Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Lisdexamfetamine Dimesylate Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Lisdexamfetamine Dimesylate Capsules Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Lisdexamfetamine Dimesylate Capsules Value Chain Analysis
  2. 13.1.1 Lisdexamfetamine Dimesylate Capsules Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Lisdexamfetamine Dimesylate Capsules Production Mode & Process
  6. 13.2 Lisdexamfetamine Dimesylate Capsules Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Lisdexamfetamine Dimesylate Capsules Distributors
  9. 13.2.3 Lisdexamfetamine Dimesylate Capsules Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst